Physician profile
Marc Angud
NPI 1598128571
$6,792.25
in general payments reported to CMS, 2019-2025
18 companies · $535 in 2025
The $535 reported for 2025 was more than what 78% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $347 · 2022: $295 · 2023: $985 · 2024: $4,631 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,661 · Travel and Lodging: $1,490.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,660.66 |
| Travel and Lodging | $1,490.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,618.20 | 2023-2025 | Linq II, Mycarelink, Micra |
| Atricure, INC. | $2,575.68 | 2022-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Biosense Webster, INC. | $401.09 | 2023-2025 | Carto 3 |
| Abbott Laboratories | $273.02 | 2023-2025 | Aveir |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $257.67 | 2021-2024 | Lifevest |
| Boston Scientific Corporation | $191.01 | 2021-2022 | |
| Pfizer INC. | $115.20 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $88.30 | 2022 | |
| Becton, Dickinson and Company | $46.00 | 2025 | Hemosphere |
| W. L. Gore & Associates, INC. | $44.65 | 2021-2022 | |
| Chiesi USA, INC. | $40.64 | 2023-2025 | Kengreal |
| Inari Medical, INC. | $37.09 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Teleflex LLC | $23.74 | 2025 | Turnpike |
| Elutia, INC. | $19.12 | 2022 | |
| Edwards Lifesciences Corporation | $17.77 | 2025 | Pascal |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.64 | 2024 | |
| Kiniksa Pharmaceuticals, LTD. | $14.03 | 2023 | Arcalyst |
| Cardiovascular Systems INC. | $13.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Angud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.